跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM NITRITE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SODIUM NITRITE INJECTION, USP
Authorized
STANDARD
SODIUM NITRITE INJECTION, USP
HOPE PHARMACEUTICALS LTD
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fc872798c7d427d3
Company
HOPE PHARMACEUTICALS LTD
Type
Standard
Approval Details
Approval Id
fc872798c7d427d3
Drug Approval Canada Name
SODIUM NITRITE INJECTION, USP
Product Name
SODIUM NITRITE INJECTION, USP
Status
Restricted Access
Status Date
2021-07-13
Original Market Date
2016-07-20
Din
02440466
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
91:00.00
Atc Original
V03AB08 SODIUM NITRITE
Atc Name
v 03 ab 08
Aig Number
0104384004
Company Name
HOPE PHARMACEUTICALS LTD
Company Address
170, 422 Richards Street, Vancouver, British Columbia, Canada, V6B 2Z4
Company Detail Path
/organization/hope-pharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
HOPE PHARMACEUTICALS LTD
Country Name
Israel
Province Name
Central District
City Name
tel aviv-jaffa,central district,country_il
Address
6 Itzhak Sade
Active Ingredients
SODIUM NITRITE
30 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fc872798c7d427d3
Type
Standard
Back to Health Canada Approvals